Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GET1 pseudogene 1 (GET1P1) is classified as a pseudogene in Homo sapiens, also known as tryptophan rich basic protein pseudogene 1 (WRBP1). It is not known to encode a functional protein and is annotated as a non-coding genomic locus. This distinguishes GET1P1 from the protein-coding GET1 gene, which encodes a membrane receptor involved in the insertion of tail-anchored proteins into the endoplasmic reticulum membrane. There are no established biological functions, disease associations, drug interactions, or recognized therapeutic roles for GET1P1. Key Clarifications: - GET1P1 is a non-functional pseudogene, not a protein-coding gene nor a therapeutic target. - It is distinct from the functional GET1 gene/protein, which is involved in endoplasmic reticulum processes. - There are no drugs, biomarkers, or safety concerns associated with GET1P1. Information is extremely limited beyond its classification as a pseudogene, and it should not be confused with protein-coding targets of therapeutic relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GET1 pseudogene 1 (GET1P1).